Schedule 13G ownership disclosure

GALECTO INC

Common Stock, $0.00001 par value per share · CUSIP: 36322Q107

Event date: 2026-02-28

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Ikarian Capital, LLC

    Shares: 335,710 · Class: 0.6%

  • Neil Shahrestani

    Shares: 335,710 · Class: 0.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-26-096746
Form type
SCHEDULE 13G/A
Filer
Damora Therapeutics, Inc.
CIK
CIK 1800315
Filed
Mar 06, 2026
Reporting period
Feb 28, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub